Evidence map›Paper›PMID 36337936›Full record

ArticleRSC advances2022

Selective synthesis of 3-formylbenzofuran and 3-acylbenzofuran using a chalcone rearrangement strategy.

Akira Nakamura, Akira Imamiya, Yuichiro Ikegami, Fei Rao, Harumi Yuguchi, Yasuyoshi Miki, Tomohiro Maegawa

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Akira NakamuraSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.ORCID https://orcid.org/0000-0002-4469-6519
Akira ImamiyaSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.
Yuichiro IkegamiSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.
Fei RaoSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.
Harumi YuguchiSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.
Yasuyoshi MikiSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.
Tomohiro MaegawaSchool of Pharmaceutical Sciences, Kindai University 3-4-1 Kowakae Higashi-osaka Osaka 577-8502 Japan maegawa@phar.kindai.ac.jp.ORCID https://orcid.org/0000-0003-1580-1110
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed a method for highly selective synthesis of two benzofuran isomers, by rearranging and subsequently transforming 2-hydroxychalcones. Depending on the reaction conditions, synthesis of 3-formylbenzofurans, unconventional products, and 3-acylbenzofurans was achieved through cyclized 2,3-dihydrobenzofurans obtained from the rearranged products. The facile synthesis of 3-formylbenzofurans facilitated synthesis of the natural product, puerariafuran, from the corresponding chalcone.

Identifiers

PMID36337936
PMCPMC9593264
OpenAlexW4308551932

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.